advertisement
Khawaja AP 76
Showing records 1 to 25 | Display all abstracts from Khawaja AP126791 Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?
Kim J
Investigative Ophthalmology and Visual Science 2025; 66: 57
126136 Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
Li K
eLife 2025; 14:
126713 Validation of a Visual Field Prediction Tool for Glaucoma: A Multicenter Study Involving Patients With Glaucoma in the United Kingdom
Dean A
American Journal of Ophthalmology 2025; 272: 87-97
124991 Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Li K
bioRxiv : the preprint server for biology 2025; 0:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Sit AJ
Survey of Ophthalmology 2025; 70: 918-929
125309 Association of Systemic Calcium Channel Blocker Use with Visual Field Progression in a Large Real-World Cohort from Glaucoma Clinics
Montesano G
Ophthalmology. Glaucoma 2025; 0:
124991 Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Tolman N
bioRxiv : the preprint server for biology 2025; 0:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Aihara M
Survey of Ophthalmology 2025; 70: 918-929
125309 Association of Systemic Calcium Channel Blocker Use with Visual Field Progression in a Large Real-World Cohort from Glaucoma Clinics
Rabiolo A
Ophthalmology. Glaucoma 2025; 0:
126136 Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
Tolman N
eLife 2025; 14:
124991 Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Tolman N
bioRxiv : the preprint server for biology 2025; 0:
126791 Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?
Kang JH
Investigative Ophthalmology and Visual Science 2025; 66: 57
126136 Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
Tolman N
eLife 2025; 14:
126713 Validation of a Visual Field Prediction Tool for Glaucoma: A Multicenter Study Involving Patients With Glaucoma in the United Kingdom
Fu DJ
American Journal of Ophthalmology 2025; 272: 87-97
125309 Association of Systemic Calcium Channel Blocker Use with Visual Field Progression in a Large Real-World Cohort from Glaucoma Clinics
Garway-Heath DF
Ophthalmology. Glaucoma 2025; 0:
124991 Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Segrè AV
bioRxiv : the preprint server for biology 2025; 0:
126136 Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
Segrè AV
eLife 2025; 14:
124991 Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Segrè AV
bioRxiv : the preprint server for biology 2025; 0:
126791 Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?
Wiggs JL
Investigative Ophthalmology and Visual Science 2025; 66: 57
126713 Validation of a Visual Field Prediction Tool for Glaucoma: A Multicenter Study Involving Patients With Glaucoma in the United Kingdom
Zhalechian M
American Journal of Ophthalmology 2025; 272: 87-97
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Khawaja AP
Survey of Ophthalmology 2025; 70: 918-929
126136 Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
Segrè AV
eLife 2025; 14:
126791 Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?
Zhao H
Investigative Ophthalmology and Visual Science 2025; 66: 57
126713 Validation of a Visual Field Prediction Tool for Glaucoma: A Multicenter Study Involving Patients With Glaucoma in the United Kingdom
Van Oyen MP
American Journal of Ophthalmology 2025; 272: 87-97
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Lin SC
Survey of Ophthalmology 2025; 70: 918-929
